Graeme Bell

Graeme Bell

Keine laufenden Positionen mehr
59 Jahre
Health Technology
Finance
Technology Services

Profil

Graeme Bell is the founder of Valuecycle LLC.
Mr. Bell is currently an Independent Director at Averin Capital Acquisition Corp.
since 2026, a Director at Cytoimmune Therapeutics, Inc. since 2023, a Director at Mindstate Design Labs, Inc. since 2025, and Group Chief Financial Officer at Owkin, Inc. since 2025.
Formerly, Mr. Bell was CEO, Chief Financial & People Officer at Valo Health, Inc. and Valo Health LLC from 2020 to 2024, Director-Investor Relations at Merck & Co., Inc. from 2007 to 2009, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC from 2015 to 2016, CFO, Principal Accounting Officer & Executive VP at Intellia Therapeutics, Inc. from 2016 to 2018, Chief Financial Officer at Tmunity Therapeutics, Inc. from 2018 to 2020, Director-Claims Development at Uris Group Ltd., and Head-Finance at Organon Pharma (UK) Ltd. Education includes an MBA from the University of Durham.

Aktive Positionen von Graeme Bell

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 01.03.2023
Finanzdirektor/CFO 01.05.2025
Direktor/Vorstandsmitglied 01.12.2025

Ehemalige bekannte Positionen von Graeme Bell

UnternehmenPositionEnde
Vorstandsvorsitzender 18.11.2024
Vorstandsvorsitzender 18.11.2024
Finanzdirektor/CFO 01.06.2020
INTELLIA THERAPEUTICS, INC. Finanzdirektor/CFO 03.08.2018
ANACOR PHARMACEUTICALS INC Finanzdirektor/CFO 01.11.2016
Sehen Sie sich die Erfahrung von Graeme Bell im Detail an

Ausbildung von Graeme Bell

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Technology Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Graeme Bell